2026 Q1 Portfolio Activity
In 2026 Q1, a16z Capital Management, L.L.C. maintained a portfolio of 17 distinct positions. The most significant new addition was DAMORA THERAPEUTICS INC, now representing 2.48% of the total fund value. The fund also reduced its exposure to OMADA HEALTH INC by 33.3%.
Position History
hover any row below to update
Loading…
Total Positions
17
Quarter
2026 Q1
Top Holding
NAVN (28.9%)
Top 10 Concentration
96.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-17 of 17
a16z Capital Management, L.L.C. Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NAVN
NAVAN INC
|
Technology | 28.95% | 29.40% |
#1
1
Prev: #2
|
6.5 |
—
|
1,023,312 | 3.8% |
P
S
|
28,218,676 | $373,615,270 |
$16.94
+17.4%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
FIG
FIGMA INC
|
Technology | 26.23% | 38.43% |
#2
1
Prev: #1
|
6.0 |
—
|
-234,751 | -1.4% |
P
S
|
16,011,378 | $338,480,531 |
$51.87
-57.1%
|
2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
META
META PLATFORMS ...
|
Communication Services | 9.42% | 8.88% |
#3
Prev: #3
|
5.8 |
—
|
no change | no change |
P
S
|
212,531 | $121,595,361 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 6.94% | 4.64% |
#4
Prev: #4
|
4.3 |
—
|
no change | no change |
P
S
|
921,099 | $89,576,878 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NAUT
NAUTILUS BIOTEC...
|
Healthcare | 5.31% | 2.18% |
#5
4
Prev: #9
|
3.6 |
—
|
no change | no change |
P
S
|
17,653,917 | $68,497,198 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XYZ
BLOCK INC
|
Technology | 4.74% | 4.19% |
#6
Prev: #6
|
2.9 |
—
|
no change | no change |
P
S
|
1,016,697 | $61,184,825 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 4.38% | 2.79% |
#7
1
Prev: #8
|
2.8 |
—
|
no change | no change |
P
S
|
3,233,170 | $56,548,143 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 3.94% | 4.46% |
#8
3
Prev: #5
|
2.6 |
—
|
no change | no change |
P
S
|
1,702,225 | $50,811,416 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ERAS
ERASCA INC
|
Healthcare | 3.59% | 0.67% |
#9
2
Prev: #11
|
2.4 |
—
|
no change | no change |
P
S
|
2,862,500 | $46,315,250 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 2.48% | — |
#10
Prev: #—
|
4.5 |
—
|
1,236,157 | — |
NEW
|
1,236,157 | $32,016,466 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OMDA
OMADA HEALTH IN...
|
Healthcare | 2.25% | 3.46% |
#11
4
Prev: #7
|
0.9 |
—
|
-1,153,645 | -33.3% |
P
S
|
2,307,284 | $29,002,560 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CAMP
CAMP4 THERAPEUT...
|
Healthcare | 0.73% | 0.82% |
#12
2
Prev: #10
|
1.3 |
—
|
no change | no change |
P
S
|
2,125,339 | $9,372,745 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
AKTIS ONCOLOGY ...
|
|
Unknown | 0.58% | — |
#13
Prev: #—
|
3.7 |
—
|
415,000 | — |
NEW
|
415,000 | $7,424,350 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
BITGO HOLDINGS ...
|
|
Unknown | 0.42% | — |
#14
Prev: #—
|
3.7 |
—
|
666,356 | — |
NEW
|
666,356 | $5,484,110 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
DNA
GINKGO BIOWORKS...
|
Healthcare | 0.05% | 0.06% |
#15
3
Prev: #12
|
1.0 |
—
|
no change | no change |
P
S
|
108,568 | $665,522 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IPST
IP STRATEGY HOL...
|
Financial Services | 0.00% | — |
#16
Prev: #—
|
3.5 |
—
|
82,740 | — |
NEW
|
82,740 | $21,843 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HTBK
HERITAGE COMM C...
|
Financial Services | 0.00% | 0.01% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-82,740 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-17 of 17 holdings